Clinical Trials in Massachusetts

Showing 7901-7920 of 13,570 trials

Functional Outcomes of Voice Recognition Prosthesis

NCT04595071

The purpose of this study is to evaluate the use of a voice activated prosthesis interface controller for functional outcomes as compared to standard prosthesis control.

ProsthesisAmputationProsthesis User

Liberating Technologies, Inc.4 participantsStarted Nov 2019

Holliston, Massachusetts, United States

COMPLETEDPhase 26.3 miles

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

NCT02785913

This phase II trial studies how well taselisib (GDC-0032) works in treating patients with stage IV squamous cell lung cancer that has come back after previous treatment. This is a sub-study that includes all screened patients positive for the phosphoinositide 3-kinase (PI3K) biomarker. PI3K can cause tumor cells to grow more quickly. Taselisib may decrease the activity of PI3K and may be able to shrink tumors.

Recurrent Squamous Cell Lung CarcinomaStage IV Squamous Cell Lung Carcinoma

SWOG Cancer Research Network31 participantsStarted Nov 2014

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +1108 more locations

Functional Outcomes of Voice Recognition Prosthesis

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Find Trials by Condition in Massachusetts

Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device

Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases

Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum

Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

Cholinesterase Inhibitor Discontinuation

The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias

Early and Adequate Protein Feeding Post-Traumatic Injury

Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy

Topical Rapamycin to Erase Angiofibromas in TSC

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

Safety and Efficacy of Melflufen and Dexamethasone in Relapsed and/or Relapsed-Refractory Multiple Myeloma Patients

Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies

Clinical Trial Evaluating Acutrak Headless Compression Screw Fixation of Medial Malleolus Fractures

National Marrow Donor Program Long-Term Donor Follow-Up

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas